Application of LDH assay for therapeutic efficacy evaluation of ex vivo tumor models

Abstract The current standard preclinical oncology models are not able to fully recapitulate therapeutic targets and clinically relevant disease biology, evidenced by the 90% attrition rate of new therapies in clinical trials. Three-dimensional (3D) culture systems have the potential to enhance the...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Megan C. Cox, Rita Mendes, Fernanda Silva, Teresa F. Mendes, Adelyn Zelaya-Lazo, Kathleen Halwachs, Julie J. Purkal, Inês A. Isidro, Ana Félix, Erwin R. Boghaert, Catarina Brito
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/6ba6021cf4734f4ebc89722a5ae55c02
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!